News
-
-
-
-
-
-
PRESS RELEASE
Dermapharm Holding SE hits upper end of guidance range for adjusted EBITDA, primarily due to steadily growing international presence in branded business
Dermapharm Holding SE reaches upper end of adjusted EBITDA guidance range by achieving 10.8% revenue growth in 2023, proposes a dividend of EUR 0.88 per share for the year -
-
-
-
![Accesswire](/assets/images/accesswire-inline.png)
-
Cheech and Chong's Global Holding Company Takes a Stand in California Legislature
-
Aztec Samples 30.2m of 3.72 gpt Gold and 167.93 gpt Silver (5.82 gpt AuEq) from Ongoing 2024 Surface Exploration Program at Tombstone Gold-Silver Project, Arizona
-
Xcyte Digital Corp. Announces Closing of MCON Live Inc. Share Exchange and Asset Purchase
-
Terrance McCray Joins the Crestcom Network
-
Leveraging Twitter With Generative AI: Enhancing US Equity Investments
![EQS Group](/assets/images/eqs-group.png)
-
EQS-Adhoc: Flughafen Wien AG: Julian Jäger and Günther Ofner Reappointed to the Management Board of Flughafen Wien AG for a New Term of Office
-
COFICERT: COFICERT and Hédon Associés sign a strategic partnership for the deployment of the certification standard: ESG 1000
-
Form 8.3 - Lupus alpha Asset Management AG: Crest Nicholson Holdings Plc
-
Blue Cap AG: Annual General Meeting approves dividend of EUR 0.65 per share and appoints two new Supervisory Board members
-
EQS-Adhoc: Nakiki SE: Preliminary results for 2022 and 2023
![Les Echos](/assets/images/les-echos.png)
-
GUILLEMOT CORPORATION: Weekly report share buyback from June 17th 2024 to June 21st 2024
-
Statement of transactions in own shares from June 17, 2024 to June 19, 2024
-
Safran: exclusive discussions to acquire Preligens
-
PR – ICADE – Alexis de Nervaux is named Head of IT and Digital Transformation and joins Icade’s Executive Committee
-
Annual Results for 2023/2024